Drug Type Small molecule drug |
Synonyms TLI-0326 |
Action modulators, agonists |
Mechanism CACNA2D1 modulators(Voltage-gated calcium channel alpha2/delta subunit 1 modulators), μ opioid receptor agonists(Mu opioid receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingClinical |
First Approval Date- |
Regulation- |
Molecular FormulaC25H45ClMgN2O8S |
InChIKeyAZQAEECQTYCGKX-VGRVZHFZSA-N |
CAS Registry1371629-04-7 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Diabetic Neuropathies | Clinical | United States | - | |
| Fibromyalgia | Clinical | United States | - | |
| Pain | Clinical | United States | - |





